Perry A. Karsen, Director at OncoMed Pharmaceuticals Inc (OMED), bought 10,000 shares at $3.46 ($35K) on 2017-06-05, disclosed to the SEC on 2017-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CELG | SELL | 2015-05-15 | $5.4M | — | Filing → |
| CELG | SELL | 2015-02-13 | $3.4M | — | Filing → |
| CELG | SELL | 2015-01-02 | $2.2M | — | Filing → |